Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple versus guideline antiplatelet therapy after recent ischaemic stroke or TIA
2007-006749-42Phase 3Terminated
- Sponsor
- University of Nottingham
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of clopidogrel, aspirin and dipyridamole in ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by University of Nottingham. Primary endpoint: Ordinal stroke severity at 90 days. Started Oct 2008; status: terminated.
02
Drugs
clopidogrelaspirindipyridamole
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on 2007-006749-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006749-42.